AmeriChoice changes name to UnitedHealthcare Community Plan
The name change is meant to unify AmeriChoice with other Medicaid health plans under the UnitedHealthcare banner.
The AmeriChoice Public Sector Health Plan in New York is now UnitedHealthcare Community Plan thank to a name change.
The change is meant to unify AmeriChoice with other Medicaid health plans under the UnitedHealthcare banner. United acquired AmeriChoice in 2002. It has since expanded from four states to operate in 20 additional states and the District of Columbia. UnitedHealthcare Community & State serves more than 3 million members in government-sponsored healthcare programs.
By aligning its health benefit companies under a common brand, UnitedHealth Group looks to continue to strengthen its care provider networks and improve service to its members.
The company, which will continue to be based in New York, will complete its transition to the new name this year.
Mental Health Comorbidities Affect Uptravi Prescribing for PAH
October 23rd 2024New real-world data suggest that physicians are cautious about prescribing the prostacyclin-receptor agonist Uptravi (selexipag) to pulmonary arterial hypertension (PAH) patients with mental health conditions when evidence suggests that it is best to take a proactive approach to treating PAH.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
Patient Advocacy Groups and Caretaker Diversity in Metastatic Breast Cancer Research
October 22nd 2024Stephanie Graff, M.D., FACP, FASCO, director of breast oncology at the Lifespan Cancer Institute and author of Investigating the Salience of Clinical Meaningfulness and Clinically Meaningful Outcomes in Metastatic Breast Cancer Care Delivery, shares the reasons why she chose to study metastatic breast cancer patients.
Read More
